WeVote

Bill

WeVote Research Nonpartisan
Bill Summary · LC 4349

Legislative bill overview

LC 4349 is a Montana bill in early draft stages that would revise existing laws governing chemical abortion (medication-induced abortion). The bill's specific provisions are not yet publicly detailed as it remains in the legislative drafting process. Chemical abortion typically refers to abortion induced through medication rather than surgical procedures, primarily using mifepristone and misoprostol.

Why is this important

Chemical abortion access and regulation significantly impact healthcare delivery, reproductive autonomy, and public health outcomes. Montana's approach to these laws affects medical practitioners' ability to provide care, patients' access to this abortion method, and the state's regulatory framework around reproductive healthcare generally.

Potential points of contention

  • Scope of restrictions vs. access: Whether the bill restricts or expands chemical abortion availability, including questions about medication access, gestational limits, and telemedicine delivery
  • Provider requirements: Potential mandates regarding physician involvement, licensing, physical presence, or reporting requirements that could affect healthcare delivery
  • Alignment with federal law: How Montana law interacts with FDA approval of mifepristone and potential federal policy changes under different administrations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.